Medical Research Council Human Immunology Unit, University of Oxford, Oxford OX3 9DS, United Kingdom.
York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, United Kingdom.
J Biol Chem. 2020 Apr 10;295(15):5036-5050. doi: 10.1074/jbc.RA119.011992. Epub 2020 Feb 7.
Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) mediates the docking and entry of dendritic cells to lymphatic vessels through selective adhesion to its ligand hyaluronan in the leukocyte surface glycocalyx. To bind hyaluronan efficiently, LYVE-1 must undergo surface clustering, a process that is induced efficiently by the large cross-linked assemblages of glycosaminoglycan present within leukocyte pericellular matrices but is induced poorly by the shorter polymer alone. These properties suggested that LYVE-1 may have limited mobility in the endothelial plasma membrane, but no biophysical investigation of these parameters has been carried out to date. Here, using super-resolution fluorescence microscopy and spectroscopy combined with biochemical analyses of the receptor in primary lymphatic endothelial cells, we provide the first evidence that LYVE-1 dynamics are indeed restricted by the submembranous actin network. We show that actin disruption not only increases LYVE-1 lateral diffusion but also enhances hyaluronan-binding activity. However, unlike the related leukocyte HA receptor CD44, which uses ERM and ankyrin motifs within its cytoplasmic tail to bind actin, LYVE-1 displays little if any direct interaction with actin, as determined by co-immunoprecipitation. Instead, as shown by super-resolution stimulated emission depletion microscopy in combination with fluorescence correlation spectroscopy, LYVE-1 diffusion is restricted by transient entrapment within submembranous actin corrals. These results point to an actin-mediated constraint on LYVE-1 clustering in lymphatic endothelium that tunes the receptor for selective engagement with hyaluronan assemblages in the glycocalyx that are large enough to cross-bridge the corral-bound LYVE-1 molecules and thereby facilitate leukocyte adhesion and transmigration.
淋巴管内皮透明质酸受体 1(LYVE-1)通过选择性地与其在白细胞表面糖萼中的配体透明质酸结合,介导树突状细胞与淋巴管的对接和进入。为了有效地结合透明质酸,LYVE-1 必须经历表面聚类,这一过程可被白细胞细胞周基质中存在的大交联糖胺聚糖有效地诱导,但仅由较短的聚合物诱导效果较差。这些特性表明 LYVE-1 在血管内皮质膜中的流动性可能有限,但迄今为止尚未对这些参数进行任何生物物理研究。在这里,我们使用超分辨率荧光显微镜和光谱学以及对原代淋巴管内皮细胞中受体的生化分析,首次提供证据表明 LYVE-1 动力学确实受到亚膜下肌动蛋白网络的限制。我们表明,肌动蛋白的破坏不仅增加了 LYVE-1 的侧向扩散,而且增强了透明质酸结合活性。然而,与相关的白细胞透明质酸受体 CD44 不同,后者利用其细胞质尾部中的 ERM 和锚蛋白基序结合肌动蛋白,LYVE-1 与肌动蛋白的直接相互作用很少(如果有的话),如通过共免疫沉淀所确定的。相反,正如超分辨率受激发射损耗显微镜与荧光相关光谱学结合所示,LYVE-1 的扩散受到亚膜下肌动蛋白围栏内的瞬时捕获的限制。这些结果表明,肌动蛋白介导的淋巴管内皮 LYVE-1 聚类的限制调节了受体选择性与糖萼中足够大的透明质酸组装体结合,从而促进白细胞黏附和迁移。